Long-term Cardiovascular Outcomes in Patients with Omicron COVID-19 and Elevated Cardiac Biomarkers: A Prospective Multicenter Cohort Study in Shanghai, China
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.112282 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Shun Yao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, China. Hauptthemen laut MEDLINE: COVID-19, Natriuretic Peptide, Brain, Troponin T, Peptide Fragments. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The long-term cardiovascular outcomes of SARS-CoV-2 omicron-infected patients remain unclear. This study aimed to evaluate acute and long-term cardiovascular risks in hospitalized omicron-infected patients with elevated cardiac biomarkers.
Methods
We included 3012 patients hospitalized in Shanghai, China, between December 1, 2022, and January 31, 2023. Participants were stratified into four groups based on cardiac troponin T (cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels. Major adverse cardiovascular events (MACEs), all-cause death, cardiovascular death, and cardiovascular-related rehospitalization were evaluated over a 12-month follow-up.
Results
Patients with elevated cTnT and high NT-proBNP had significantly higher risks of MACEs (HRadj=2.85, 95% CI 1.58-5.12), all-cause death (HRadj=5.56, 95% CI 1.51-20.52), cardiovascular death (HRadj=11.97, 95% CI 1.40-102.46), and cardiovascular-related rehospitalization (HRadj=2.38, 95% CI 1.28-4.42). The finding of Subgroup analyses indicated the risk of MACEs were independent of age, gender, hypertension, coronary artery disease, acute coronary syndrome, or heart failure.
Conclusions
Elevated cTnT and NT-proBNP levels during the acute phase of omicron infection predict a substantially increased risk of adverse cardiovascular outcomes within 12 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, China.
- Institutes of Biomedical Sciences Fudan University, Shanghai, China.
- Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Cardiology, Huadong Hospital, Fudan University, Shanghai, China.
- Department of Emergency, Zhongshan Hospital, Fudan University, Shanghai, China.
Zitieren
APA
Yao, S., Xu, Y., Xie, Z., Yuan, S., Gao, J., Chen, Q., Shi, K., Liu, Z., Cui, X., Wang, Y., Song, Y., Han, X., Ge, J., Song, Z., & Zhou, J. (2025). Long-term Cardiovascular Outcomes in Patients with Omicron COVID-19 and Elevated Cardiac Biomarkers: A Prospective Multicenter Cohort Study in Shanghai, China. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.112282
Vancouver
Yao S, Xu Y, Xie Z, Yuan S, Gao J, Chen Q, et al. Long-term Cardiovascular Outcomes in Patients with Omicron COVID-19 and Elevated Cardiac Biomarkers: A Prospective Multicenter Cohort Study in Shanghai, China. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.112282
BibTeX
@article{Yao2025,
author = {Yao, Shun and Xu, Yamei and Xie, Zhonglei and Yuan, Shuai and Gao, Junqing and Chen, Qianwei and Shi, Kailei and Liu, Zongjun and Cui, Xiaotong and Wang, Yanyan and Song, Yu and Han, Xueting and Ge, Junbo and Song, Zhenju and Zhou, Jingmin},
title = {Long-term Cardiovascular Outcomes in Patients with Omicron COVID-19 and Elevated Cardiac Biomarkers: A Prospective Multicenter Cohort Study in Shanghai, China},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.112282}
}
EUVIMED